Eledon Pharmaceuticals, Inc. Earnings Per Share (Basic)
Eledon Pharmaceuticals, Inc. (ELDN) reported Earnings Per Share (Basic) of -$0.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.27.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.33.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.10.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.21, a 120.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$0.52.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$0.66.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$4.73.
- Eledon Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$6.16.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.27 10-Q · filed 2026-08-13 | -$0.59 10-Q · filed 2026-08-13 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.33 10-Q · filed 2026-05-13 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.52 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.42 10-Q · filed 2025-11-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$0.13 10-Q · filed 2026-08-13 | -$0.21 10-Q · filed 2026-08-13 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.01 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.08 10-Q · filed 2026-05-13 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-05-13 | $0.16 derived: net income ÷ weighted average shares · filed 2026-05-13 | |||||
| 2024-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-03-19 | $0.28 derived: net income ÷ weighted average shares · filed 2026-03-19 | -$0.66 10-K · filed 2026-03-19 | -$0.75 10-K · filed 2025-03-20 | ||||
| 2024-09-30 | $1.05 10-Q · filed 2025-11-14 | $0.13 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | -$0.92 10-Q · filed 2025-08-14 | -$1.06 10-Q · filed 2024-08-19 | -$1.61 10-Q · filed 2025-08-14 | -$1.90 10-Q · filed 2024-08-19 | ||||
| 2024-03-31 | -$0.65 10-Q/A · filed 2025-08-14 | -$0.34 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$4.73 10-K · filed 2025-03-20 | -$1.64 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | -$0.33 10-Q · filed 2024-11-12 | -$0.35 10-Q · filed 2023-11-09 | -$3.79 10-Q · filed 2024-11-12 | -$1.35 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$2.74 10-K/A · filed 2024-08-19 | -$0.40 10-Q · filed 2023-08-10 | -$3.99 10-K/A · filed 2024-08-19 | -$1.06 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$0.75 10-Q/A · filed 2024-08-19 | |||||||
| 2022-12-31 | -$6.16 10-K/A · filed 2024-08-19 | |||||||
| 2022-09-30 | -$0.73 10-Q · filed 2023-11-09 | -$2.07 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.65 10-Q · filed 2023-08-10 | -$1.34 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$0.69 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$2.33 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$0.66 10-Q · filed 2022-11-14 | -$1.73 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.50 10-Q · filed 2022-08-11 | -$1.07 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |